{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:54:46Z","timestamp":1781848486423,"version":"3.54.5"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric infectious mononucleosis (IM) caused by Epstein\u2013Barr virus (EBV) poses diagnostic challenges due to overlapping clinical presentations with other febrile illnesses. This study aimed to characterize immune function alterations in children with EBV-associated IM and evaluate the diagnostic performance of peripheral blood lymphocyte subsets and cytokine profiles, individually and in combination, to support early diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between June 2024 and January 2026, pediatric patients with EBV-associated IM (IM group) and healthy children serving as controls (HC group) were prospectively enrolled. Lymphocyte subsets were quantified by flow cytometry, and plasma cytokines were measured by cytometric bead array (CBA). Inter-group differences were analyzed statistically, and receiver operating characteristic (ROC) curve analysis was used to evaluate diagnostic performance of individual and combined biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 61 children with IM and 32 healthy controls were enrolled. The predominant clinical manifestations in the IM group included fever (88.9%), pharyngitis (92.1%), lymphadenopathy (85.7%), tonsillar hypertrophy (90.4%), and periorbital edema (33.3%). Compared with the HC group, patients with IM demonstrated significantly elevated white blood cell counts, absolute lymphocyte counts, platelet counts, hemoglobin levels, and hepatic transaminases (ALT, AST) along with lactate dehydrogenase (LDH) (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Immunophenotyping showed absolute counts of total lymphocytes, CD3\u207a T cells, CD8\u207a T cells, NK cells and percentages of CD3 and CD8 were significantly higher (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05) in the IM group, whereas CD4%, CD4\/CD8 ratio, CD19%, and NK% were significantly decreased (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Cytokine analysis demonstrated significant elevation of IL-6, IL-10, TNF-\u03b1, IFN-\n                      <jats:italic>\u03b3<\/jats:italic>\n                      , IL-17, IFN-\u03b1, and IL-12p70 in the IM group compared to the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). ROC analysis identified superior diagnostic performance for absolute counts of total lymphocytes (AUC=0.959), CD3\u207a T cells (AUC=0.957), and CD8\u207a T cells (AUC=0.972) among individual parameters. Combined lymphocyte subset analysis yielded an AUC of 0.995 (sensitivity 0.969, specificity 0.983), while combined cytokine assessment achieved an AUC of 0.980 (sensitivity 0.938, specificity 0.931), both substantially outperforming single biomarkers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pediatric IM is characterized by profound immune activation with marked CD8\u207a T cell expansion and elevated pro-inflammatory cytokines alongside the immunoregulatory cytokine IL-10. Combined assessment of lymphocyte subsets and cytokines significantly enhances IM diagnostic accuracy and holds substantial clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1836759","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:47:08Z","timestamp":1781848028000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic value of combined flow cytometry-based detection of peripheral blood lymphocyte subsets and cytokines for pediatric infectious mononucleosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Kai","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingran","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiao","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e60329","DOI":"10.7759\/CUREUS.60329","article-title":"Infectious mononucleosis revealed by non-steroidal anti-inflammatory drug: a first clinical report","volume":"16","author":"Ahmed","year":"2024","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8383","DOI":"10.1038\/s41467-024-52195-8","article-title":"Risk of inflammatory bowel disease following hospitalisation with infectious mononucleosis: nationwide cohort study from Denmark","volume":"15","author":"Ebert","year":"2024","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein\u2013Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J Clin Virol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e00071","DOI":"10.1128\/spectrum.00071-25","article-title":"Epstein\u2013Barr virus (EBV) serology and its impact on oral human papillomavirus (HPV) infection outcomes in children during early childhood","volume":"13","author":"Rinne","year":"2025","journal-title":"Microbiol Spectr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.coi.2010.12.014","article-title":"Immune defence against EBV and EBV-associated disease","volume":"23","author":"Long","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein\u2013Barr virus in vivo","volume":"187","author":"Callan","year":"1998","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e200250","DOI":"10.1212\/NXI.0000000000200250","article-title":"Ocrelizumab alters cytotoxic lymphocyte function while reducing EBV-specific CD8+ T-cell proliferation in patients with multiple sclerosis","volume":"11","author":"Abbadessa","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12879-025-10573-z","article-title":"The prevalence and influence of EBV infection in patients with severe fever with thrombocytopenia syndrome","volume":"25","author":"Geng","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1652825","DOI":"10.3389\/fped.2025.1652825","article-title":"Immunological profile and its clinical implications in pediatric infectious mononucleosis","volume":"13","author":"Wang","year":"2025","journal-title":"Front Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"33976","DOI":"10.1038\/s41598-025-33976-x","article-title":"Impact of Epstein\u2013Barr virus reactivation on cytokine levels in pregnant women with malaria in the west region of Cameroon","volume":"15","author":"Chatue","year":"2025","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.1038\/s41467-025-62163-3","article-title":"Biomarkers of pediatric Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis through single-cell transcriptomics","volume":"16","author":"Shen","year":"2025","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein\u2013Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1028972","DOI":"10.3389\/fimmu.2022.1028972","article-title":"Epstein\u2013Barr virus, interleukin-10 and multiple sclerosis: a m\u00e9nage \u00e0 trois","volume":"13","author":"Sch\u00f6nrich","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3760\/cma.j.cn112140-20210618-00513","article-title":"National cooperative group on pediatric Epstein\u2013Barr virus infection. Expert consensus on the diagnosis and treatment principles of Epstein\u2013Barr virus-associated diseases in children","volume":"59","year":"2021","journal-title":"Chin J Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/biom12010038","article-title":"Co-stimulatory molecules during immune control of Epstein\u2013Barr virus infection","volume":"12","author":"M\u00fcnz","year":"2022","journal-title":"Biomolecules"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e200460","DOI":"10.1212\/NXI.0000000000200460","article-title":"Epstein\u2013Barr virus in multiple sclerosis: past, present, and future","volume":"12","author":"Wahbeh","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2020.07.011","article-title":"Cytotoxicity in epstein barr virus specific immune control","volume":"46","author":"M\u00fcnz","year":"2021","journal-title":"Curr Opin Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"E46","DOI":"10.1002\/pbc.24480","article-title":"Cytokine profiles in children with primary Epstein\u2013Barr virus infection","volume":"60","author":"Wada","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1040-8428(01)00200-0","article-title":"Immunological aspects of Epstein\u2013Barr virus infection","volume":"44","author":"Ohga","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1060053","DOI":"10.3389\/fped.2023.1060053","article-title":"Characteristics of immunological events in Epstein\u2013Barr virus infection in children with infectious mononucleosis","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2024037","DOI":"10.4084\/MJHID.2024.037","article-title":"Lymphocytes in patients with chronic active Epstein\u2013Barr virus disease exhibited elevated PD-1\/PD-L1 expression and a prevailing Th2 immune response","volume":"16","author":"Sun","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","article-title":"Chronic active Epstein\u2013Barr virus disease","volume":"8","author":"Kimura","year":"2017","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00277-025-06249-6","article-title":"Predicting 30-day mortality in hemophagocytic lymphohistiocytosis: clinical features, biochemical parameters, and machine learning insights","volume":"104","author":"Zhu","year":"2025","journal-title":"Ann Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/bjh.15988","article-title":"Requirement for etoposide in the initial treatment of Epstein\u2013Barr virus-associated haemophagocytic lymphohistiocytosis","volume":"186","author":"Yue","year":"2019","journal-title":"Br J Haematol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1100\/tsw.2011.62","article-title":"Advances in hemophagocytic lymphohistiocytosis: pathogenesis, early diagnosis\/differential diagnosis, and treatment","volume":"11","author":"Tang","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"B26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1182\/hematology.2025000080","article-title":"Hemophagocytic lymphohistiocytosis: do we have a solution for TMI (too much inflammation)?","volume":"2025","author":"La Ros\u00e9e","year":"2025","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","article-title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency)","volume":"117","author":"Schmid","year":"2011","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein\u2013Barr virus infection in university students","volume":"207","author":"Balfour","year":"2013","journal-title":"J Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein\u2013Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1084\/jem.20160248","article-title":"Epstein\u2013Barr viral miRNAs inhibit antiviral CD4\u207a T cell responses targeting IL-12 and peptide processing","volume":"213","author":"Tagawa","year":"2016","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1243366","DOI":"10.3389\/fmolb.2024.1243366","article-title":"An IL-17A-centric response to Epstein\u2013Barr virus DNA mediated by dendritic cell-T cell interactions","volume":"11","author":"Shehab","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1002704","DOI":"10.1371\/journal.ppat.1002704","article-title":"The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination","volume":"8","author":"Jochum","year":"2012","journal-title":"PLoS Pathog"},{"key":"B35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/jmv.21445","article-title":"Regulatory T cell activity in primary and persistent Epstein\u2013Barr virus infection","volume":"81","author":"Wingate","year":"2009","journal-title":"J Med Virol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1836759\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:47:09Z","timestamp":1781848029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1836759\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":35,"alternative-id":["10.3389\/fped.2026.1836759"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1836759","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"article-number":"1836759"}}